MicroRNA-193b-3p represses neuroblastoma cell growth via downregulation of Cyclin D1, MCL-1 and MYCN
Open Access
- 6 April 2018
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 9 (26) , 18160-18179
Abstract
Neuroblastoma is the most common diagnosed tumor in infants and the second most common extracranial tumor of childhood. The survival rate of patients with high-risk neuroblastoma is still very low despite intensive multimodal treatments. Therefore, new treatment strategies are needed. In recent years, miRNA-based anticancer therapy has received growing attention. Advances in this novel treatment strategy strongly depends on the identification of candidate miRNAs with broad-spectrum antitumor activity. Here, we identify miR-193b as a miRNA with tumor suppressive properties. We show that miR-193b is expressed at low levels in neuroblastoma cell lines and primary tumor samples. Introduction of miR-193b mimics into nine neuroblastoma cell lines with distinct genetic characteristics significantly reduces cell growth in vitro independent of risk factors such as p53 functionality or MYCN amplification. Functionally, miR-193b induces a G1 cell cycle arrest and cell death in neuroblastoma cell lines by reducing the expression of MYCN, Cyclin D1 and MCL-1, three important oncogenes in neuroblastoma of which inhibition has shown promising results in preclinical testing. Therefore, we suggest that miR-193b may represent a new candidate for miRNA-based anticancer therapy in neuroblastoma.Keywords
This publication has 71 references indexed in Scilit:
- MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive reviewEMBO Molecular Medicine, 2012
- Neuronal differentiation by TAp73 is mediated by microRNA-34a regulation of synaptic protein targetsProceedings of the National Academy of Sciences, 2011
- miR-193b Regulates Mcl-1 in MelanomaThe American Journal of Pathology, 2011
- Expression of miR-487b and miR-410 encoded by 14q32.31 locus is a prognostic marker in neuroblastomaBritish Journal of Cancer, 2011
- Tumour-suppressor microRNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastomaBritish Journal of Cancer, 2011
- Recent Advances in NeuroblastomaNew England Journal of Medicine, 2010
- Deep sequencing reveals differential expression of microRNAs in favorable versus unfavorable neuroblastomaNucleic Acids Research, 2010
- BH3 response profiles from neuroblastoma mitochondria predict activity of small molecule Bcl-2 family antagonistsCell Death & Differentiation, 2009
- MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cellsOncogene, 2007
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001